News

Check out market updates

Edgewise Therapeutics raises $95M to fund muscular-dystrophy drug trials

BOULDER — Edgewise Therapeutics Inc. has more than doubled its previous fundraising rounds by closing a $95 million Series C […]
Source: BizWest

Leave a Reply

Your email address will not be published. Required fields are marked *

X